Aperio Group’s Loxo Oncology, Inc LOXO Stock Holding History

Aperio Group’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,102	Closed	-$295K	–	2340
2018 Q4	$295K	Sell	2,102 -222	-10%	-$33.7K	﹤0.01%	1955
2018 Q3	$397K	Buy	2,324 +562	+32%	+$94.4K	﹤0.01%	1892
2018 Q2	$306K	Buy	+1,762	New	+$265K	﹤0.01%	1990

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Aperio Group's LOXO Position: Q1 2019 in Review

Aperio Group sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 2,102 shares — an estimated $295K sold.

Aperio Group first reported a position in LOXO in Q2 2018 and held it in 3 quarters. The position peaked at $397K in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Aperio Group reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Aperio Group sold 2,102 Loxo Oncology, Inc shares in Q1 2019, an estimated $295K.
Aperio Group first reported a position in Loxo Oncology, Inc in Q2 2018 and held it in 3 quarters.
Aperio Group's Loxo Oncology, Inc position peaked at $397K in Q3 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Aperio Group's 13F filing for Q1 2019, filed 13 May 2019.